Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/1559
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorMACHADO-VIEIRA, Rodrigo-
dc.date.accessioned2013-07-30T17:53:35Z-
dc.date.available2013-07-30T17:53:35Z-
dc.date.issued2012-
dc.identifier.citationJOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, v.32, n.5, p.735-736, 2012-
dc.identifier.issn0271-0749-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/1559-
dc.language.isoeng-
dc.publisherLIPPINCOTT WILLIAMS & WILKINS-
dc.relation.ispartofJournal of Clinical Psychopharmacology-
dc.rightsrestrictedAccess-
dc.subject.otherdouble-blind-
dc.subject.otherallopurinol-
dc.subject.otherefficacy-
dc.subject.otherlithium-
dc.subject.othermodel-
dc.titlePurinergic System in the Treatment of Bipolar Disorder Uric Acid Levels as a Screening Test in Mania-
dc.typearticle-
dc.rights.holderCopyright LIPPINCOTT WILLIAMS & WILKINS-
dc.identifier.doi10.1097/JCP.0b013e318268391d-
dc.identifier.pmid22926622-
dc.subject.wosPharmacology & Pharmacy-
dc.subject.wosPsychiatry-
dc.type.categoryletter-
dc.type.versionpublishedVersion-
hcfmusp.description.beginpage735-
hcfmusp.description.endpage736-
hcfmusp.description.issue5-
hcfmusp.description.volume32-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84865860737-
hcfmusp.origem.idWOS:000308671800034-
hcfmusp.publisher.cityPHILADELPHIA-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceAkhondzadeh S, 2006, BIPOLAR DISORD, V8, P485, DOI 10.1111/j.1399-5618.2006.00363.x-
hcfmusp.relation.referenceANUMONYE A, 1968, J GERONTOL B-PSYCHOL, V1, P1290-
hcfmusp.relation.referenceBowman GL, 2010, J ALZHEIMERS DIS, V25, P49-
hcfmusp.relation.referenceChung KH, 2010, PSYCHIAT RES, V180, P147, DOI 10.1016/j.psychres.2009.07.012-
hcfmusp.relation.referenceDe Berardis D, 2008, J BIOL REG HOMEOS AG, V22, P195-
hcfmusp.relation.referenceJinnah HA, 2009, DIS MODEL MECH, V2, P116, DOI 10.1242/dmm.002543-
hcfmusp.relation.referenceKraeplin E., 1921, MANIC DEPRESSIVE INS-
hcfmusp.relation.referenceLara DR, 2006, PROG NEURO-PSYCHOPH, V30, P617, DOI 10.1016/j.pnpbp.2006.02.002-
hcfmusp.relation.referenceLorenzi TM, 2010, J AFFECT DISORDERS, V121, P161, DOI 10.1016/j.jad.2009.05.023-
hcfmusp.relation.referenceMachado-Vieira R, 2001, J CLIN PSYCHOPHARM, V21, P621, DOI 10.1097/00004714-200112000-00017-
hcfmusp.relation.referenceMachado-Vieira R, 2002, MED HYPOTHESES, V58, P297, DOI 10.1054/mehy.2001.1543-
hcfmusp.relation.referenceMachado-Vieira R, 2008, J CLIN PSYCHIAT, V69, P1237-
hcfmusp.relation.referenceMcQuillin A, 2009, MOL PSYCHIATR, V14, P614, DOI 10.1038/mp.2008.6-
hcfmusp.relation.referenceSalvadore G, 2010, PROG NEURO-PSYCHOPH, V34, P819, DOI 10.1016/j.pnpbp.2010.02.027-
dc.description.indexMEDLINE-
hcfmusp.lim.ref2012-
hcfmusp.citation.scopus30-
hcfmusp.scopus.lastupdate2024-04-12-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - LIM/27
LIM/27 - Laboratório de Neurociências


Files in This Item:
File Description SizeFormat 
art_MACHADO-VIEIRA_Purinergic_System_in_the_Treatment_of_Bipolar_Disorder_2012.PDF
  Restricted Access
publishedVersion (English)2.05 MBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.